Please provide your email address to receive an email when new articles are posted on . Remote ICD deactivation for patients receiving hospice care was successful in a small feasibility study.

Patients with heart failure (HF) and left ventricular (LV) dysfunction have been shown to derive clinical benefit from cardiac resynchronization therapy (CRT) and from implantable ...

For older patients without an indication for pacing, the subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) provides results comparable to those seen with traditional ...

Implantable cardioverter defibrillators (ICDs) were found to have a beneficial effect on mortality in patients with chronic kidney disease (CKD). Mortality in patients with chronic kidney disease (CKD ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In certain patients with an ICD for primary prevention, ...

Prophylactic implantable cardioverter defibrillator therapy did not reduce mortality in patients with a prior myocardial infarction, persistent moderate left ventricular systolic dysfunction and ...

AURORA, CO — Almost 80% of older patients who received an implantable cardioverter defibrillator (ICD) for secondary prevention after being resuscitated for cardiac arrest lived at least 2 years ...

March 9, 2004 (New Orleans) — In addition to the survival benefit achieved with best medical treatment, an implantable cardiac defibrillator (ICD) reduced mortality by 23% in patients with New York ...

"Appropriately selected patients with NICM have the potential to benefit from primary prevention ICD therapy…Besides consideration of ICD placement, attention to guideline-directed medical therapy and ...

NEW ORLEANS -- Implanted devices that can shock a failing heart back into regular rhythm do an excellent job of keeping patients alive, two new University of Michigan studies find. The research also ...

Many rare diseases don't have an ICD code, and the National Center for Advancing Translational Sciences (NCATS) at NIH is exploring ways to best expand those codes to benefit rare disease patients and ...